Literature DB >> 3025263

Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.

F Wang, R M Blaese, K C Zoon, G Tosato.   

Abstract

Suppression and/or cytotoxicity are believed to play an important role in the defense against Epstein-Barr virus (EBV) infection. To analyze the role of suppressor T cells in relation to EBV, we sought to clone and study these T cells. Analysis of 152 T cell clones derived from the peripheral blood of two patients with acute EBV-induced infectious mononucleosis (IM) yielded 11 highly suppressive clones that had no cytotoxic activity for the natural killer sensitive K562 cell line, an autologous EBV-infected cell line, or an allogeneic EBV-infected B cell line. Four of six suppressor T cell clones also profoundly inhibited EBV-induced immunoglobulin production, and five of five clones delayed the outgrowth of immortalized cells. These results indicate that during acute IM, suppressor T cells capable of inhibiting B cell activation in the absence of cytotoxicity can be identified, and may play a key role in the control of EBV infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3025263      PMCID: PMC423971          DOI: 10.1172/JCI112810

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

Review 1.  Epstein-Barr virus infection and immunoregulation in man.

Authors:  G Tosato; R M Blaese
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

Review 2.  The changing faces of EBV research.

Authors:  G Klein; E Klein
Journal:  Prog Med Virol       Date:  1984

3.  Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells.

Authors:  M G Masucci; M T Bejarano; G Masucci; E Klein
Journal:  Cell Immunol       Date:  1983-03       Impact factor: 4.868

4.  Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).

Authors:  G Tosato; S Straus; W Henle; S E Pike; R M Blaese
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

5.  Relationship between immunoglobulin production and immortalization by Epstein Barr virus.

Authors:  G Tosato; R M Blaese; R Yarchoan
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

6.  Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma.

Authors:  M Lotz; C D Tsoukas; S Fong; D A Carson; J H Vaughan
Journal:  Eur J Immunol       Date:  1985-05       Impact factor: 5.532

7.  Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody.

Authors:  P J Martin; H M Shulman; W H Schubach; J A Hansen; A Fefer; G Miller; E D Thomas
Journal:  Ann Intern Med       Date:  1984-09       Impact factor: 25.391

8.  Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.

Authors:  P C Patel; G Dorval; J Menezes
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

9.  Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells.

Authors:  R Yarchoan; G Tosato; R M Blaese; R M Simon; D L Nelson
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors:  R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Emergence of non-major-histocompatibility-complex-restricted lytic CD8+ cells in the blood of nasopharyngeal carcinoma patients.

Authors:  M Lakhdar; H Thameur; M Maalej; F Ben Ayed; A Ladgham
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

3.  An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes.

Authors:  D Liebowitz; R Kopan; E Fuchs; J Sample; E Kieff
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

4.  Heat shock protein 90 expression in Epstein-Barr virus-infected B cells promotes gammadelta T-cell proliferation in vitro.

Authors:  Maria Kotsiopriftis; Jerome E Tanner; Caroline Alfieri
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Urushiol (poison ivy)-triggered suppressor T cell clone generated from peripheral blood.

Authors:  R S Kalish; C Morimoto
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.